Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
86 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-HALOPERIDOL | 10MG | TABLET | Resolved | 2022-08-18 | 2023-06-09 | 167171 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167174 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167177 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167179 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2021-04-01 | 2021-06-10 | 136755 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138317 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140375 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140690 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Actual shortage | 2025-05-08 | 2025-05-11 | 256908 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2022-12-01 | 2023-01-26 | 176758 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110697 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110700 |
TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Resolved | 2020-04-10 | 2020-05-08 | 111868 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
TEVA-IMATINIB | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124974 |
TEVA-IMATINIB | 100MG | TABLET | Resolved | 2019-08-22 | 2019-11-14 | 92148 |
TEVA-IMATINIB | 400MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134334 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |
TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |